Recent updates on the role of chemotherapy in pancreatic cancer

被引：34
作者：
Burris, HA
机构：
[1] Sarah Cannon Canc Ctr, Nashville, TN USA
[2] Tennessee Oncol PLLC, Nashville, TN USA
来源：
SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 04期
关键词：
D O I：
10.1053/j.seminoncol.2005.06.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S3
页数：3
相关论文
共 15 条
  • [1] BERLIN J, 2001, P AN M AM SOC CLIN, V20, P127
  • [2] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    Burris, HA
    Moore, MJ
    Andersen, J
    Green, MR
    Rothenberg, ML
    Madiano, MR
    Cripps, MC
    Portenoy, RK
    Storniolo, AM
    Tarassoff, P
    Nelson, R
    Dorr, FA
    Stephens, CD
    VanHoff, DD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2403 - 2413
  • [3] Cheverton P, 2004, J CLIN ONCOL, V22, p314S
  • [4] HEINEMANN V, 2003, P AN M AM SOC CLIN, V22, P250
  • [5] Kindler HL, 2004, J CLIN ONCOL, V22, p315S
  • [6] KINDLER HLL, 2004, CHEM FDN P NEW YORK, V24, P28
  • [7] Louvet C, 2004, J CLIN ONCOL, V22, p315S
  • [8] Maples WJ, 2004, J CLIN ONCOL, V22, p333S
  • [9] MAPLES WJ, 2004, THALIDOMIDE GEMCITAB
  • [10] Moore MJ, 2005, J CLIN ONCOL, V23, p1S
12